DE2356017A1 - Pyridinderivate, verfahren zu deren herstellung und sie enthaltende mittel - Google Patents

Pyridinderivate, verfahren zu deren herstellung und sie enthaltende mittel

Info

Publication number
DE2356017A1
DE2356017A1 DE2356017A DE2356017A DE2356017A1 DE 2356017 A1 DE2356017 A1 DE 2356017A1 DE 2356017 A DE2356017 A DE 2356017A DE 2356017 A DE2356017 A DE 2356017A DE 2356017 A1 DE2356017 A1 DE 2356017A1
Authority
DE
Germany
Prior art keywords
compounds
compound
release
therapeutically acceptable
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE2356017A
Other languages
German (de)
English (en)
Inventor
Peder Bernhard Berntsson
Per Arvid Emil Carlsson
Hans Rudolf Corrodi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of DE2356017A1 publication Critical patent/DE2356017A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2356017A 1972-11-16 1973-11-09 Pyridinderivate, verfahren zu deren herstellung und sie enthaltende mittel Ceased DE2356017A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7214872A SE373850B (fi) 1972-11-16 1972-11-16

Publications (1)

Publication Number Publication Date
DE2356017A1 true DE2356017A1 (de) 1974-06-06

Family

ID=20299803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2356017A Ceased DE2356017A1 (de) 1972-11-16 1973-11-09 Pyridinderivate, verfahren zu deren herstellung und sie enthaltende mittel

Country Status (17)

Country Link
JP (1) JPS5732058B2 (fi)
AR (1) AR204160A1 (fi)
AT (1) AT333278B (fi)
BE (1) BE806228A (fi)
CA (1) CA976553A (fi)
CH (1) CH586679A5 (fi)
DE (1) DE2356017A1 (fi)
DK (1) DK137898B (fi)
ES (1) ES420359A1 (fi)
FI (1) FI55652C (fi)
FR (1) FR2206942B1 (fi)
GB (1) GB1429068A (fi)
IE (1) IE38516B1 (fi)
NL (1) NL7315294A (fi)
SE (1) SE373850B (fi)
SU (1) SU482945A3 (fi)
ZA (1) ZA737973B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7909514L (sv) 1979-11-16 1981-05-17 Astra Laekemedel Ab Nya halofenyl-pyridyl-allylaminderivat

Also Published As

Publication number Publication date
DK137898C (fi) 1978-11-20
CA976553A (en) 1975-10-21
GB1429068A (en) 1976-03-24
FR2206942A1 (fi) 1974-06-14
IE38516B1 (en) 1978-03-29
FR2206942B1 (fi) 1977-01-28
FI55652C (fi) 1979-09-10
DK137898B (da) 1978-05-29
AT333278B (de) 1976-11-10
CH586679A5 (fi) 1977-04-15
JPS5732058B2 (fi) 1982-07-08
AR204160A1 (es) 1975-11-28
AU6216573A (en) 1975-05-08
NL7315294A (fi) 1974-05-20
ATA938573A (de) 1976-03-15
BE806228A (fr) 1974-02-15
FI55652B (fi) 1979-05-31
IE38516L (en) 1974-05-16
ES420359A1 (es) 1976-04-01
JPS49133379A (fi) 1974-12-21
ZA737973B (en) 1974-10-30
SE373850B (fi) 1975-02-17
SU482945A3 (ru) 1975-08-30

Similar Documents

Publication Publication Date Title
DE2657013C2 (de) 1-(3-Dimethylaminopropyl)-phthalane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2405094A1 (de) 2-aminoindan-abkoemmlinge, deren herstellung und verwendung
DE2035517C3 (de) 11 -Aminoalkylidenmorphanthridine sowie Verfahren zu deren Herstellung
DE1915230A1 (de) Hydroxyphenylalkylaminderivate und Verfahren zu deren Herstellung
DE2356017A1 (de) Pyridinderivate, verfahren zu deren herstellung und sie enthaltende mittel
DE2348577C2 (de) 1-Amino-4-phenyl-1,2,3,4-tetrahydronaphthaline, deren pharmakologisch verträglichen Salze und diese enthaltende pharmazeutische Zubereitungen
DE2738131A1 (de) Aminoketone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CH620195A5 (fi)
DE2755017C2 (fi)
DE2166662C3 (de) Dibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH615665A5 (en) Process for the preparation of the Z-isomer of 3-(4-bromophenyl)-N-methyl-3-(3-pyridyl)allylamine
EP0192098B1 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
CH621538A5 (fi)
DE2220333A1 (de) Pyridinderivate, verfahren zu deren herstellung und deren verwendung
DE2043188A1 (de) Neue Oxazolindenvate, ihre Her stellung und Verwendung
DE1518444C (de) erythro alpha Phenyl beta amino propanole, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arz neimittel
DE2636328A1 (de) Arzneimittel
DE3706399A1 (de) Mittel mit antidepressiver wirkung
DE2204989C3 (de) 2-Phenyl-3-(beta-dlmethylaminopropionyl)benzoturan und dessen pharmakologisch verträgliche Säureadditionssalze sowie diese Verbindungen enthaltende Arzneimittel
DE68905278T2 (de) Pharmazeutische zusammensetzungen.
DE2421549A1 (de) Naphthalinderivate, verfahren zu ihrer herstellung und arzneimittel
DE2729530C3 (de) Verwendung von 4-Methyl-l-homopiperazindithiocarbonsäure und deren Salzen
DE2638849A1 (de) Aminosaeureester, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
AT360001B (de) Verfahren zur herstellung von neuen phthalan- -derivaten und ihren pharmazeutisch ver- traeglichen saeureadditionssalzen
AT329577B (de) Verfahren zur herstellung von neuen 2- (morpholino) -1-(3-trifluormethylphenyl)-propanderivaten ihren salzen und optischen isomeren

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: ASTRA LAEKEMEDEL AB, 15185 SOEDERTAELJE, SE

8131 Rejection